Jon Våbenø

Jon Våbenø

Auto-generated profile, based on publicly available information

Jon Våbenø

Helgeland Hospital Trust, Sandnessjøen, Norway

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MASSIMILIANO PIO DI CAGNOMASSIMILIANO PIO DI CAGNO
MASSIMILIANO PIO DI CAGNO
FCFabrizio Clarelli
Fabrizio Clarelli
JVJon Våbenø
Jon Våbenø
CLChristina Lesley
Christina Lesley
SRSokar Darsim Rahman
Sokar Darsim Rahman
PSPaul C Stein
Paul C Stein

12 May 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
AJAstrid S. Jørgensen
Astrid S. Jørgensen
VDViktorija Daugvilaite
Viktorija Daugvilaite
KFKatia De Filippo
Katia De Filippo
CBChristian Berg
Christian Berg
MMMasa Mavri
Masa Mavri
MRmette rosenkilde
mette rosenkilde
Following the FDA-approval of the hematopoietic stem cell (HSC) mobilizer plerixafor, orally available and potent CXCR4 antagonists were pursued. One such proposition was AMD11070, which was orally active and had superior antagonism in vitro; however, it did not appear as effective for HSC mobilization in vivo. Here we show that while AMD11070 acts as a full antagonist, plerixafor acts biased by stimulating β-arrestin recruitment while fully antagonizing G protein. Consequently, while AMD11070 prevents the constitutive receptor internalization, plerixafor allows it and thereby decreases receptor expression. These findings are confirmed by the successful transfer of both ligands’ binding sites and action to the related CXCR3 receptor. In vivo, plerixafor exhibits superior HSC mobilization associated with a dramatic reversal of the CXCL12 gradient across the bone marrow endothelium, which is not seen for AMD11070. We propose that the biased action of plerixafor is central for its superior therapeutic effect in HSC mobilization.

24 November 2014 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
STS Thiele
S Thiele
JMJ Mungalpara
J Mungalpara
ASA Steen
A Steen
MRmette rosenkilde
mette rosenkilde
JVJ Våbenø
J Våbenø

26 November 2002 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
JVJon Våbenø
Jon Våbenø
MBMagnus Brisander
Magnus Brisander
TLTore Lejon
Tore Lejon
KLKristina Luthman
Kristina Luthman

10 August 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JVJon Våbenø
Jon Våbenø
Carsten Uhd NielsenCarsten Uhd Nielsen
Carsten Uhd Nielsen
TITruls Ingebrigtsen
Truls Ingebrigtsen
TLTore Lejon
Tore Lejon
BSBente Steffansen
Bente Steffansen
KLKristina Luthman
Kristina Luthman

6 January 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JVJon Våbenø
Jon Våbenø
TLTore Lejon
Tore Lejon
Carsten Uhd NielsenCarsten Uhd Nielsen
Carsten Uhd Nielsen
BSBente Steffansen
Bente Steffansen
WCWeiqing Chen
Weiqing Chen
KLKristina Luthman
Kristina Luthman